The “collateral story” may be more complicated than previously thought, highlighting the need for more research into their evolution and role.

Read more »

The most inclusive criteria from both trials should be adopted, experts conclude.…

Read more »

More information is needed on factors that may promote potentially harmful effects of these microbleeds, researchers say.…

Read more »


The lack of difference in clinical outcomes between the two strategies may reflect the limited power of the study, researchers say.…

Read more »

Time from symptom onset stretched to 24 hours, and age over 80 years no longer considered a barrier to treatment in the new SNIS recommendations.…

Read more »

Page 8 of 43